| 42 | As adjunctive therapy to improve the neurologic outcome following subarachnoid haemorrhage during the acute management period (within 4 days of haemorrhage). |
| | LU Authorization Period: 1 year |
| 43 | As prophylaxis of ischemia if surgery is delayed. |
| | LU Authorization Period: 1 year |
